临床药师利用PDCA法参与脑梗死临床路径效果评价

目的 探讨临床药师参与脑梗死临床路径管理的方法和临床效果.方法 选取重庆市合川区人民医院2016年1月至2017年6月的252例脑梗死临床路径病例,对照组为常规脑梗死临床路径病例,观察组为临床药师参与的脑梗死临床路径病例.观察组又以PDCA循环法对脑梗死临床药师路径进行完善,共进行2个循环.主要观察比较患者的住院费用、药品费用、住院时间、并发症发生率及用药依从性.结果 观察组患者的住院费用、药品费用、住院时间、并发症发生率及用药依从性均优于对照组(P＜0.01).观察组中第2个周期患者的上述指标均优于第1个周期(P＜0.05).结论 临床药师利用PDCA法参与临床路径管理,有利于降低患者住院费用,缩短住院时间,减少并发症,提高患者用药依从性.

Evaluation on effect of clinical pharmacists using PDCA to participate in the clinical pathway of cerebral infarction

Objective To explore the methods that clinical pharmacists' participation in the clinical path management of cerebral infarction.Methods A total of 252 cases of cerebral infarction from January 2016 to June 2017 in People's Hospital of Hechuan District were selected.The control group (n=126) received conventional cerebral infarction clinical pathway.However,clinical pharmacists were participated in the observation group (n=126);In the observation group,the pathway of clinical pharmacists for cerebral infarction was improved by the PDCA circulation method,and a total of 2 cycles were performed.The hospitalization and medicine cost,hospitalization time,complication rate,as well as medication compliance were observed and compared.Results The hospitalization expenses,medicine expenses,hospitalization time,complication rate and medication compliance of patients in the observation group were better than that in control group (P＜0.01).The indicators above of the observation group for the second cycles in patients were better than that of the first cycle (P＜0.05).Conclusion The participation of clinical pharmacists using PDCA method in clinical pathway management is helpful to reduce hospitalization expenses and complications and improve medication compliance in patients with cerebral infarction.